229 related articles for article (PubMed ID: 7543740)
1. Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.
Kong FM; Anscher MS; Murase T; Abbott BD; Iglehart JD; Jirtle RL
Ann Surg; 1995 Aug; 222(2):155-62. PubMed ID: 7543740
[TBL] [Abstract][Full Text] [Related]
2. Preoperative transforming growth factor-beta 1 (TGF-beta 1) plasma levels in operable breast cancer patients.
Chod J; Zavadova E; Halaska MJ; Strnad P; Fucikova T; Rob L
Eur J Gynaecol Oncol; 2008; 29(6):613-6. PubMed ID: 19115689
[TBL] [Abstract][Full Text] [Related]
3. Plasma transforming growth factor beta levels in breast cancer patients.
Sminia P; Barten AD; van Waarde MA; Vujaskovic Z; van Tienhoven G
Oncol Rep; 1998; 5(2):485-8. PubMed ID: 9468585
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of transforming growth factor beta1 in patients with breast cancer.
Sheen-Chen SM; Chen HS; Sheen CW; Eng HL; Chen WJ
Arch Surg; 2001 Aug; 136(8):937-40. PubMed ID: 11485532
[TBL] [Abstract][Full Text] [Related]
5. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
Shariat SF; Shalev M; Menesses-Diaz A; Kim IY; Kattan MW; Wheeler TM; Slawin KM
J Clin Oncol; 2001 Jun; 19(11):2856-64. PubMed ID: 11387358
[TBL] [Abstract][Full Text] [Related]
6. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.
Blackwell K; Haroon Z; Broadwater G; Berry D; Harris L; Iglehart JD; Dewhirst M; Greenberg C
J Clin Oncol; 2000 Feb; 18(3):600-8. PubMed ID: 10653875
[TBL] [Abstract][Full Text] [Related]
7. Influence of tumor histology on preoperative staging accuracy of breast metastases to the axilla.
Hackney L; Williams S; Bajwa S; Morley-Davies AJ; Kirby RM; Britton I
Breast J; 2013; 19(1):49-55. PubMed ID: 23186153
[TBL] [Abstract][Full Text] [Related]
8. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression.
Ivanović V; Todorović-Raković N; Demajo M; Nesković-Konstantinović Z; Subota V; Ivanisević-Milovanović O; Nikolić-Vukosavljević D
Eur J Cancer; 2003 Mar; 39(4):454-61. PubMed ID: 12751375
[TBL] [Abstract][Full Text] [Related]
10. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
[TBL] [Abstract][Full Text] [Related]
12. Overall survival and clinicopathological characteristics of patients with breast cancer in relation to the expression pattern of HER-2, IL-6, TNF-α and TGF-β1.
Tripsianis G; Papadopoulou E; Romanidis K; Katotomichelakis M; Anagnostopoulos K; Kontomanolis E; Botaitis S; Tentes I; Kortsaris A
Asian Pac J Cancer Prev; 2013; 14(11):6813-20. PubMed ID: 24377611
[TBL] [Abstract][Full Text] [Related]
13. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in breast cancer New indications and our experience.
Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
[TBL] [Abstract][Full Text] [Related]
16. [Sentinel lymph node detection in patients with breast carcinoma].
Reuhl T; Haensch W; Markwardt J; Schlag PM
Zentralbl Chir; 1998; 123 Suppl 5():72-4. PubMed ID: 10063579
[TBL] [Abstract][Full Text] [Related]
17. Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients.
Pierce A; Saldova R; Abd Hamid UM; Abrahams JL; McDermott EW; Evoy D; Duffy MJ; Rudd PM
Glycobiology; 2010 Oct; 20(10):1283-8. PubMed ID: 20581008
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection.
Shim KS; Kim KH; Han WS; Park EB
Cancer; 1999 Feb; 85(3):554-61. PubMed ID: 10091729
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes.
Wei S; Bleiweiss IJ; Nagi C; Jaffer S
Clin Breast Cancer; 2014 Aug; 14(4):280-4. PubMed ID: 24581736
[TBL] [Abstract][Full Text] [Related]
20. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes.
Plecha D; Bai S; Patterson H; Thompson C; Shenk R
Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
